Tenofovir Alafenamide Tablets
IIT-20210825-0020-01
Approved small_molecule active
Quick answer
Tenofovir Alafenamide Tablets for Chronic Hepatitis b is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Chronic Hepatitis b
- Phase
- Approved
- Modality
- small_molecule
- Status
- active